The Female and the Fragile X Reviewed

ABSTRACT

Nearly 15 years ago, female carriers of the fragile X mental retardation syndrome were noted to have an increased incidence of twin pregnancies. Since then, much evidence has accumulated supporting the notion of ovarian dysfunction in fragile X carriers, in the forms of increased dizygotic twinning and premature ovarian failure. However, despite a decade and a half of research regarding this association, the underlying mechanism remains a mystery. This article reviews the population-based studies that have examined this association and discusses possible reasons for the variations in results. In addition, results from more recent studies on endocrine function in fragile X carriers are discussed. These data, when considered in conjunction with our emerging understanding of the molecular biology of the fragile X gene (FMR1) and its protein product (FMRP), are beginning to elucidate possible mechanisms for the association between fragile X syndrome and ovarian dysfunction.

KEYWORD

Fragile X syndrome - FMR1, FMRP - premature ovarian failure - trinucleotide repeat

REFERENCES

• 1 Lehrke R G. (1974) X-linked mental retardation and verbal disability. In: Bergsma D, ed. Birth Defects: Original Article Series New York: The National Foundation 1981: 1-100
• 2 Martin J P, Bell J. A pedigree of mental defect showing sex-linkage.  J Neurol Psychiatry . 1943;  6 154-157
• 3 Fu Y H, Kuhl D P, Pizzuti A. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.  Cell . 1991;  67 1047-1058
• 4 Rousseau F, Heitz D, Biancalana V. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation.  N Engl J Med . 1991;  325 1673-1681
• 5 Sutcliffe J S, Nelson D L, Zhang F. DNA methylation represses FMR-1 transcription in fragile X syndrome.  Hum Mol Genet . 1992;  1 397-400
• 6 Pieretti P C, Sismani C, Hettinger J A. Absence of expression of the FMR-1 gene in fragile X syndrome.  Cell . 1991;  66 817-822
• 7 Albright S G, Lachiewicz A M, Tarleton J C. Fragile X phenotype in a patient with a large de novo deletion in Xq27-q28.  Am J Med Genet . 1994;  51 294-297
• 8 Hirst M, Grewel P, Flannery A. Two new cases of FMR1 deletion associated with mental impairment.  Am J Hum Genet . 1995;  56 67-74
• 9 Kooy R F, D'Hooge R, Reyniers E. Transgenic mouse model for the fragile X syndrome.  Am J Med Genet . 1996;  64 241-245
• 10 Mannermaa A, Pulkkinen L, Kajanoja E, Ryynanen M, Saarikoski S. Deletion in the FMR1 gene in a fragile-X male.  Am J Med Genet . 1996;  64 293-295
• 11 Paradee W, Melikian H E, Rasmussen D L, Kenneson A, Conn P J, Warren S T. Fragile X mouse: strain effects of knock-out phenotype and evidence suggesting deficient amygdala function.  Neuroscience . 1999;  94 185-192
• 12 Tarleton J, Richie R, Schwartz C, Rao K, Aylsworth A S, Lachiewicz A. An extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype.  Hum Mol Genet . 1993;  2 1973-1974
• 13 Warren S T, Nelson D L. Advances in molecular analysis of fragile X syndrome.  JAMA . 1994;  271 536-542
• 14 Brown W T, Friedman E, Jenkins E C. Association of the fragile X syndrome with autism.  Lancet . 1982;  1 100
• 15 Brown W T, Jenkins E C, Friedman E. Autism is associated with fragile X syndrome.  J Autism Dev Disord . 1982;  12 303-308
• 16 Fisch G S. Is autism associated with the fragile X syndrome?.  Am J Med Genet . 1992;  43 47-55
• 17 Reiss A L, Freund L. Fragile X syndrome, DSM-III-R, and autism.  J Am Acad Child Adolesc Psychiatry . 1990;  29 885-891
• 18 Fisch G S, Holden J J, Simensen R. Is fragile X syndrome a pervasive developmental disability?.  Am J Med Genet . 1994;  51 346-352
• 19 Reiss A L, Hagerman R J, Vinogradov S, Abrams M, King R J. Psychiatric disability in female carriers of the fragile X chromosome.  Arch Gen Psychiatry . 1988;  45 25-30
• 20 Freund L S, Resii A L, Abrams M T. Psychiatric disorders associated with fragile X in the young female.  Pediatrics . 1993;  91 321-329
• 21 Franke P, Maier W, Hautzinger M. Fragile-X carrier females: evidence for a distinct psychopathological phenotype?.  Am J Med Genet . 1996;  64 334-339
• 22 Rousseau F, Heitz D, Tarleton J. A multi-center study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.  Am J Hum Genet . 1994;  55 225-237
• 23 Snow K, Doud L K, Hagerman R, Pergolizzi R G, Erster S H, Thibodeau S N. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.  Am J Hum Genet . 1993;  53 1217-1228
• 24 Sobesky W E, Hull C E, Hagerman R J. Symptoms of schizotypal personality disorder in fragile X women.  J Am Acad Child Adolesc Psychiatry . 1994;  33 247-255
• 25 Thompson N M, Gulley M L, Rogeness G A. Neurobehavioral characteristics of CGG amplification status in fragile X females.  Am J Med Genet . 1994;  54 378-383
• 26 Franke P, Leboyer M, Gansicke M. Genotype-phenotype relationship in female carriers of the permutation and full mutation of the FMR-1.  Psychiatry Res . 1998;  80 113-127
• 27 Sobesky W E, Taylor A K, Pennington B F. Molecular/ clinical correlations in females with fragile X.  Am J Med Genet . 1996;  64 340-345
• 28 Dorn M B, Mazzocco M M, Hagerman R J. Behavioral and psychiatric disorders in adult male carriers of fragile X.  J Am Acad Child Adolesc Psychiatry . 1994;  33 256-264
• 29 Hull C, Hagerman R J. A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.  Am J Dis Child . 1993;  147 1236-1241
• 30 Loesch D Z, Hay D A, Mulley J. Transmitting males and carrier females in fragile X: revisited.  Am J Med Genet . 1994;  51 392-399
• 31 Riddle J E, Ceema A, Sobesky W E. Phenotypic involvement in females with the FM-1 gene mutation.  Am J Ment Retard . 1998;  102 590-601
• 32 Fryns J P. The female and the fragile X: a study of 144 obligate female carriers.  Am J Med Genet . 1986;  23 157-169
• 33 Centers for Disease Control. State-specific variation in twin births: United States, 1992-1994.  MMWR Morb Mortal Wkly Rep . 1997;  46 121-125
• 34 Lykken D T, Bouchard T JJ, McGue M, Tellegen A. Minnesota Twin Family Study: The Minnesota Twin Family Registry: Some Initial Findings. Minneapolis: University of Minnesota; 2000
• 35 Meyers C, Adam R, Dungan J, Pregner V. Aneuploidy in twin gestations: when is maternal age advanced?.  Obstet Gynecol . 1997;  89 248-251
• 36 Moore K L. The Developing Human: Clinical Oriented Embryology.  Philadelphia: WB Saunders; 1988
• 37 Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman R J. Heterozygous fragile X females: historical, physical, cognitive, and cytogenetic features.  Am J Med Genet . 1991;  38 269-274
• 38 Krauss C M, Turksoy N, Atkins L, McLaughlin C, Brown L G, Page D C. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome.  N Engl J Med . 1987;  317 125-131
• 39 Powell C M, Taggart R T, Drumheller T C, Wangsa D C, Nelson L M, White B J. Molecular and cytogenetic studies of an X/autosome translocation in a patient with premature ovarian failure and review of the literature.  Am J Med Genet . 1994;  52 19-26
• 40 Schwartz C, Fitch N, Phelan M C, Richer C-L, Steveson R. Two sisters with a distal deletion at the Xq26/Xq27 interface: DNA studies indicate that the gene locus for factor IX is present.  Hum Genet . 1987;  76 54-57
• 41 Skibsted L, Welsh H, Niebuhr. X long-arm deletions: a review of non-mosaic cases studied with banding techniques.  Hum Genet . 1994;  67 1-5
• 42 Veneman T F, Beverstock G C, Exalto N, Mollevanger P. Premature menopause because of an inherited deletion in the long arm on the X-characterization.  Fertil Steril . 1991;  55 631-633
• 43 Partington M W, Moore D Y, Turner G M. Confirmation of early menopause in fragile X carriers.  Am J Med Genet . 1996;  64 370-372
• 44 Tizzano E F, Baiget M. High proportion of twins in carriers of fragile X syndrome.  J Med Genet . 1992;  29 599
• 45 Sherman S L, Turner G, Sheffield L, Laing S, Robinson H. Investigation of the twinning rate in families with the fragile X syndrome.  Am J Med Genet . 1988;  30 625-631
• 46 Murray A, Ennis S, MacSwiney F, Webb J, Morton N E. Reproductive and menstrual history of females with fragile X expansions.  Eur J Hum Genet . 2000;  8 247-252
• 47 Allingham-Hawkins D J, Babul-Hirji R, Chitayat D. Fragile X premutations is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X Study-preliminary data.  Am J Med Genet . 1999;  83 322-325
• 48 Schwartz C E, Dean J, Howard-Peebles P N. Obstetrical and gynecological complications in fragile X carriers: a multi-center study.  Am J Med Genet . 1994;  51 400-402
• 49 Uzielli M LG, Guarducci S, Lapi E. Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.  Am J Med Genet . 1999;  84 300-303
• 50 Conway G S, Hettiarachi S, Murray A, Jacobs P A. Fragile X premutations in familial premature ovarian failure.  Lancet . 1995;  346 309-310
• 51 Conway G S, Payne N N, Webb J, Murray A, Jacobs P A. Fragile X premutation screening in women with premature ovarian failure.  Hum Reprod . 1998;  13 1184-1187
• 52 Marozzi A, Vegetti W, Manfredini E. Association between idiopathic premature ovarian failure and fragile X premutations.  Hum Reprod . 2000;  15 197-202
• 53 Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature menopause.  J Med Genet . 1998;  35 637-640
• 54 Syrrou M, Georgiou I, Patsalis P C, Bouba I, Adonakis G, Pagoulatos G N. Fragile X permutation and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction.  Am J Med Genet . 1999;  84 306-309
• 55 Rousseau F, Rouillard P, Morel M L, Khandjian E W, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene, and implications for the population genetics of the fragile X syndrome.  Am J Hum Genet . 1995;  57 1006-1018
• 56 Spence W C, Black S H, Fallon L. Molecular fragile X screening in normal populations.  Am J Med Genet . 1996;  64 181-183
• 57 Driscoll G, Clark J, Elakis G, Turner G. Early menopause in a family carrying a fragile X permutation.  Aust N Z J Med . 2000;  30 86-88
• 58 Layman L L, Gupta J, Xie J, Song M, Das S. Fragile X FMR1 premutation alleles with premature ovarian failure in families with at least one full mutation.  Am J Hum Genet . 1998;  A334 (A334)
• 59 Vianna-Morgante A M, Costa S S, Pares A S, Verreschi I T. FRAXA premutation associated with premature ovarian failure.  Am J Med Genet . 1996;  64 373-375
• 60 Kenneson A, Cramer D E, Warren S T. Fragile X premutations are not a major cause of early menopause.  Am J Hum Genet . 1997;  61 1362-1369
• 61 Marozzi A, Dalpra L, Ginelli E, Tibiletti M G, Crosignani P G. FRAXA premutations are not a cause of familial premature ovarian failure.  Hum Reprod . 1999;  14 573-575
• 62 Martin N G, Healey S C, Pangan T S, Heath A C, Turner G. Do mothers of dizygotic twins have earlier menopause?.  <~>A role for fragile X? Am J Med Genet . 1997;  69 114-116
• 63 Sherman S L, Meadows K L, Ashley A E. Examination of factors that influence the expansion of the fragile X mutation in a subset of conceptuses from known carrier females.  Am J Med Genet . 1996;  64 256-260
• 64 Hunscheind R DL, Sistermans E A, Thomas C MG. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X permutations.  Am J Hum Genet . 2000;  66 413-418
• 65 Murray A, Ennis S, Morton N. No evidence of parent of origin influencing premature ovarian failure in fragile X premutation carriers.  Am J Hum Genet . 2000;  67 253-254
• 66 Vianna-Morgante A M, Costa S S. Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X.  Am J Hum Genet . 2000;  67 254-255
• 67 Sherman S L. Premature ovarian failure among fragile X permutation carriers: parent-of-origin effect?.  Am J Hum Genet . 2000;  67 11-13
• 68 Butler M G, Najjar J L. Do some patients with fragile X syndrome have precocious puberty?.  Am J Med Genet . 1988;  31 779-781
• 69 Moore P S, Chudley A E, Winter J S. True precocious puberty in a girl with the fragile X syndrome.  Am J Med Genet . 1990;  37 265-267
• 70 Burgess B, Partington M, Turner G, Robinson J. Normal age of menarche in fragile X syndrome.  Am J Med Genet . 1996;  64 376
• 71 Black S H. Preimplantation genetic diagnosis.  Curr Opin Pediatr . 1994;  6 712-716
• 72 Howard-Peebles P N. Successful pregnancy in a fragile X carrier by donor egg.  Am J Med Genet . 1996;  64 377
• 73 Braat D DM, Smits A PT, Thomas C MG. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study.  Am J Med Genet . 1999;  83 327-328
• 74 Murray A, Webb J, MacSwiney F, Shipley E L, Morton N E, Conway G S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.  Hum Reprod . 1999;  14 1217-1218
• 75 Berkowitz G D, Wilson D P, Carpenter N J, Brown T R, Migeon C J. Gonadal function in men with the Martin-Bell (fragile X) syndrome.  Am J Med Genet . 1986;  23 227-239
• 76 Bregman J D, Leckman J F, Ort S I. Thyroid function in fragile X syndrome males.  Yale J Biol Med . 1990;  63 293-299
• 77 Cantu J M, Scaglia H E, Medina M. Inherited congenital normofunctional testicular hyperplasia and mental deficiency.  Hum Genet . 1976;  33 23-33
• 78 McDermott A, Walters R, Howell R T, Gardner A. Fragile X chromosome: clinical and cytogenetic studies on cases from seven families.  J Med Genet . 1993;  20 169-178
• 79 Moore P S, Chudley A E, Winter J S. Pituitary-gonadal axis in pubertal boys with fragile X syndrome Am J Med Genet .  1991;  39 374-375
• 80 Nielsen K B, Tommerup N, Dyggve H V, Schou C. Macroorchidism and fragile X in mentally retarded males: clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site of Xq28, fra(X)(q28).  Hum Genet . 1982;  61 113-117
• 81 O'Hare J P, O'Brien I A, Arendt J. Does melatonin deficiency cause the enlarged genitalia of the fragile X syndrome?.  Clin Endocrinol . 1986;  24 327-333
• 82 Ruvalcaba R H, Myhre S A, Roosen-Runge E C, Beckwith J B. X-linked mental deficiency megalotestes syndrome.  JAMA . 1977;  238 1646-1650
• 83 Turner G, Eastman C, Casey J, McLeay A, Procopius P, Tyrner B. X-linked mental retardation associated with macro-orchidism.  J Med Genet . 1975;  12 367-371
• 84 Venter P A, Op't Hof J, Coetzee D J. The Martin-Bell syndrome in South Africa.  Am J Med Genet . 1986;  23 597-610
• 85 Wilson D P, Carpenter N J, Berkowitz G. Thyroid function in men with fragile X-linked MR.  Am J Med Genet . 1988;  31 733-734
• 86 Abitol M, Menini C, Delezoide A L, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.  Nat Genet . 1993;  4 147-153
• 87 Hergersberg M, Mastuo K, Gassman M. Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice.  Hum Mol Genet . 1995;  4 359-366
• 88 Hinds H L, Ashley C T, Sutcliffe J S. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome [published erratum appears in Nat Genet 1995;5:312].  Nat Genet . 1993;  3 36-43
• 89 Tamanini F, Willemsen R, van Unen L. Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.  Hum Mol Genet . 1997;  6 1315-1322
• 90 Bachner D, Manca A, Steinbach P. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad.  Hum Mol Genet . 1993;  2 2043-2050
• 91 Malter H E, Iber J C, Willemsen R. Characterization of the full fragile X syndrome mutation in fetal gametes.  Nat Genet . 1997;  15 165-169
• 92 Oberle I, Rousseau F, Heitz D. Instability of a 550 base pair DNA segment and abnormal methylation in fragile X syndrome.  Science . 1991;  252 1097-1102
• 93 Reyniers E, Vits L, De Boulle K. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.  Nat Genet . 1993;  4 143-146
• 94 Pianese L, Cavalcanti F, De Michele G. The effect of parental gender on the GAA dynamic mutation in the FRDA gene.  Am J Hum Genet . 1997;  60 460-463
• 95 Eberhart D E, Warren S T. Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus.  Somat Cell Mol Genet . 1996;  22 435-441
• 96 Ashley-Koch A E, Robinson H, Glicksman A E. Examination of factors associated with instability of the FMR1 CGG repeat.  Am J Hum Genet . 1998;  63 776-785
• 97 Fisch G S, Snow K, Thibodeau S N. The fragile X syndrome permutation in carriers and its effect on mutation size in offspring.  Am J Hum Genet . 1995;  56 1147-1155
• 98 Nolin S L, Lewis III A F, Ye L L. Familial transmission of the FMR1 CGG repeat.  Am J Hum Genet . 1996;  59 1252-1261
• 99 Nolin S L, Houck Jr E G, Gargano A D. FMR1 CGG-repeat instability in single-sperm and lymphocytes of fragile-X permutation males.  Am J Hum Genet . 1999;  65 680-688
• 100 Tassone F, Hagerman R J, Taylor A K, Gane L W, Godfry T E, Hagerman P J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.  Am J Hum Genet . 2000;  66 6-15
• 101 Turner G, Eastman C, Wake S, Martin N. Dizygous twinning and premature menopause in fragile X syndrome.  Lancet . 1994;  344 1500
• 102 Vianna-Morgante A M. Twinning and premature ovarian failure in premutation fragile X carriers.  Am J Med Genet . 1999;  83 326